Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Income from licenses are twice as high as previously estimated

Re: There are a number of reasons that can be, one simple on is that the terms of the settlement don't allow PTSC to list them.

.

The settlement & license announcement was made public. So it doesn't seem logical that the ND was the reason not to list the J's as purchasers - unless they weren't.

Share
New Message
Please login to post a reply